Selection and characterization of novel DNA aptamers targeting colorectal cancer cells with malignant potential

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Analytical and Bioanalytical Chemistry

• Publication date

  2025-09-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00216-025-06091-9PMID 40890503
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Functional SELEX and Biomedical Applications of Aptamers: Beyond Molecular Recognition.

  2025cited by this paper
• Selection and identification of DNA aptamer binding VDAC1 for tumor tissue imaging and targeted drug delivery.

  2025cited by this paper
• Cancer statistics, 2025

  2025cited by this paper
• Aptamer-based microfluidics for the detection of cancer biomarkers

  2025cited by this paper
• Aptamer- vs Fab-Conjugated Liposomes: A Comparative Study in Targeting Acute Myeloid Leukemia Cells.

  2025cited by this paper
• Blocker-SELEX: a structure-guided strategy for developing inhibitory aptamers disrupting undruggable transcription factor interactions

  2024cited by this paper
• Mechanisms of metastatic colorectal cancer

  2024cited by this paper
• Development of a Specific Aptamer‐Modified Nano‐System to Treat Esophageal Squamous Cell Carcinoma

  2024cited by this paper
• Rapid detection of carcinoembryonic antigen by means of an electrochemical aptasensor

  2024cited by this paper
• Aptamer‐Encapsulated Cellular Nanoparticles for Neurotoxin Neutralization

  2024cited by this paper
• Photothermally Active Quantum Dots in Cancer Imaging and Therapeutics: Nanotheranostics Perspective.

  2024cited by this paper
• Radioimmunotherapy in colorectal cancer treatment: present and future

  2023cited by this paper
• Screening and application of inhibitory aptamers for DNA repair protein apurinic/apyrimidinic endonuclease 1.

  2023cited by this paper
• Aptamer-Protein Interactions: From Regulation to Biomolecular Detection.

  2023cited by this paper
• Aptamers 101: aptamer discovery and in vitro applications in biosensors and separations

  2023cited by this paper
• Recent advances in aptamer-based therapeutic strategies for targeting cancer stem cells

  2023cited by this paper
• Quantum Dot Nanomaterials: Preparation, Characterization, Advanced Bio-Imaging and Therapeutic Applications

  2023cited by this paper
• Recent progress of SELEX methods for screening nucleic acid aptamers.

  2023cited by this paper
• The application of Aptamer in biomarker discovery

  2023cited by this paper
• An AuNPs-Based Fluorescent Sensor with Truncated Aptamer for Detection of Sulfaquinoxaline in Water

  2022cited by this paper
• Elucidation of CKAP4-remodeled cell mechanics in driving metastasis of bladder cancer through aptamer-based target discovery

  2022cited by this paper
• Aptamer-based therapy for targeting key mediators of cancer metastasis (Review)

  2022cited by this paper
• Generation and Selection of Specific Aptamers Targeting Brucella Species through an Enhanced Cell-SELEX Methodology

  2022cited by this paper
• Identification of the target protein of the metastatic colorectal cancer-specific aptamer W3 as a biomarker by aptamer-based target cells sorting and functional characterization.

  2022cited by this paper
• Truncated Analogues of a G-Quadruplex-Forming Aptamer Targeting Mutant Huntingtin: Shorter Is Better!

  2022cited by this paper
• Metastatic recurrence in colorectal cancer arises from residual EMP1+ cells

  2022cited by this paper
• Profiling Cancer Cells by Cell-SELEX: Use of Aptamers for Discovery of Actionable Biomarkers and Therapeutic Applications Thereof

  2021cited by this paper
• Targeting Splicing Factor SRSF6 for Cancer Therapy

  2021cited by this paper
• Inhibitory Effect of Gallotannin on Lung Metastasis of Metastatic Colorectal Cancer Cells by Inducing Apoptosis, Cell Cycle Arrest and Autophagy.

  2021cited by this paper
• Comparison of Different Colorectal Cancer With Liver Metastases Models Using Six Colorectal Cancer Cell Lines

  2020cited by this paper
• Aptamer Generated by Cell-SELEX for Specific Targeting of Human Glioma Cells.

  2020cited by this paper
• Differential expression of hENT1 and hENT2 in colon cancer cell lines.

  2017cited by this paper
• SRSF6-regulated alternative splicing that promotes tumour progression offers a therapy target for colorectal cancer

  2017cited by this paper
• The impact of the RBM4-initiated splicing cascade on modulating the carcinogenic signature of colorectal cancer cells

  2017cited by this paper
• Quantitative detection of the tumor-associated antigen large external antigen in colorectal cancer tissues and cells using quantum dot probe

  2016cited by this paper
• Superior Performance of Aptamer in Tumor Penetration over Antibody: Implication of Aptamer-Based Theranostics in Solid Tumors

  2015cited by this paper
• Inhibition of TMEM16A Expression Suppresses Growth and Invasion in Human Colorectal Cancer Cells

  2014cited by this paper
• Development of DNA aptamers using Cell-SELEX

  2010cited by this paper
• Generating aptamers for recognition of virus-infected cells.

  2009cited by this paper
• Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease

  2006cited by this paper
• Publisher's Note

  2003cited by this paper
• Invasion of human colorectal carcinoma cells is promoted by endogenous basic fibroblast growth factor

  1997cited by this paper
• Human colonic adenocarcinoma cells

  1976cited by this paper

• An inertial-acoustofluidic platform for bioanalysis: concurrent, high-precision, high-throughput separation of cells and bacteria.

  2026cites this paper